These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2654952)

  • 21. [Effect of gangliosides on the cytotoxicity of natural killer cells from Syrian hamsters and sensitivity of target cells].
    Matveeva VA; Amineva SP; Kliuchareva TE; Diatlovitskaia EV; Bergel'son LD
    Dokl Akad Nauk SSSR; 1987; 292(5):1278-80. PubMed ID: 2951240
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary generation in vitro of T killer lymphocytes specific against viral tumors, in the presence of interleukine 2].
    Lévy JP; Gomard E; Wybier-Franqui J
    C R Seances Acad Sci III; 1981 Mar; 292(12):759-61. PubMed ID: 6788393
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.
    Spiess PJ; Yang JC; Rosenberg SA
    J Natl Cancer Inst; 1987 Nov; 79(5):1067-75. PubMed ID: 3500355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural cytotoxicity in the guinea-pig: the natural killer (NK) cell activity of the Kurloff cell.
    Eremin O; Coombs RR; Ashby J; Plumb D
    Immunology; 1980 Oct; 41(2):367-78. PubMed ID: 7439932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.
    Stutman O; Lattime EC; Figarella EF
    Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in lymphocyte responsiveness to lymphokines in two inbred strains of Syrian hamster.
    Wright KE; Clark DA; Rawls WE
    J Immunol; 1984 Jul; 133(1):286-92. PubMed ID: 6609982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells and tumor immunity: 1985.
    Herberman RB
    Year Immunol; 1986; 2():254-60. PubMed ID: 3033946
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of NK cell lymphokine responsiveness by pituitary-thyroid hormones during ontogeny in mice. Suggestion for a sequential neuroendocrine-immune cross-talk.
    Provinciali M; Di Stefano G; Fabris N
    Ann N Y Acad Sci; 1994 Nov; 741():73-80. PubMed ID: 7825828
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro.
    Lichtenstein AK; Pende D
    Cancer Res; 1986 Feb; 46(2):639-44. PubMed ID: 3940633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro generated mast cells express natural cytotoxicity against tumour cells.
    Ghiara P; Boraschi D; Villa L; Scapigliati G; Taddei C; Tagliabue A
    Immunology; 1985 Jun; 55(2):317-24. PubMed ID: 3924820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of natural killer cell cytotoxicity from bone marrow cells cocultivated with immune peritoneal macrophages.
    Chapes SK; Fan SS; Cummins JM; Tompkins WA
    J Reticuloendothel Soc; 1981 May; 29(5):341-55. PubMed ID: 6165823
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The induction of lymphokine-activated killer cells: increased cytotoxicity via long-term cultivation].
    Hartwig M; Körner IJ; Malz W
    Arch Geschwulstforsch; 1989; 59(2):73-7. PubMed ID: 2785787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of leukoregulin enhancement of target cell susceptibility to NK cell mediated cytotoxicity in humans.
    Ransom JH; Evans CH; McCabe RP; Hanna MG
    Adv Exp Med Biol; 1985; 184():281-7. PubMed ID: 3862336
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukemogenesis by methylnitrosourea in BDF1 mice. The origin of transplantable cells and the activity of the natural killer cells during the preleukemic period.
    Seidel HJ; Kreja L
    Nat Immun Cell Growth Regul; 1985; 4(4):193-201. PubMed ID: 4069122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro and in vivo investigation of three surface-active agents as modulators of cell proliferation.
    Tobler J; Watts MT; Fu JJ
    Cancer Res; 1980 Apr; 40(4):1173-80. PubMed ID: 7357547
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytotoxicity of bovine lymphocytes after treatment with lymphokines.
    Campos M; Rossi CR
    Am J Vet Res; 1986 Jul; 47(7):1524-8. PubMed ID: 3488701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
    Wright SC; Hiserodt JC; Bonavida B
    Transplant Proc; 1981 Mar; 13(1 Pt 2):770-3. PubMed ID: 7268895
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytotoxic cellular mediators of the immune response to neoplasia: a review.
    Khavari P
    Yale J Biol Med; 1987; 60(5):409-19. PubMed ID: 3321723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.